Exane BNP Paribas analyst Rob Jones upgraded Gecina to Outperform from Neutral with a EUR 120 price target. The analyst sees the stock as undervalued following the recent underperformance.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GECFF: